Erie Retina Research
One of the nation’s leading retina research centers, now powered by Lexitas
Lexitas and Erie Retina Research have joined forces to create a differentiated retina research ecosystem that combines specialized clinical expertise, proven enrollment performance, and innovation-driven research capabilities.
About Erie Retina Research
Led by vitreoretinal surgeon and clinician-scientist David Almeida, MD, MBA, PhD, Erie Retina Research is a premier ophthalmic research center focused on advancing therapies for retinal disease. Based in Erie, Pennsylvania, the center manages a robust portfolio of pharmaceutical and surgical studies across all phases of development. Since 2019, the team has enrolled more than 1,000 patients and earned multiple First Patient In recognitions through a reputation for operational excellence and execution.
David RP Almeida, MD, MBA, PhD
Chief Retina Strategy Officer
Dr. Almeida is an internationally recognized vitreoretinal surgeon, researcher, and healthcare innovator. He has served as Principal Investigator on more than 100 clinical trials spanning all phases of development across three continents and is widely recognized for his contributions to retinal disease research, surgical innovation, and clinical trial execution. As founder of Erie Retina Research, CASExERIE, and Element Erie, he has helped build a comprehensive ecosystem supporting therapeutic development from concept through commercialization.